Suppr超能文献

相似文献

1
FXR regulates liver repair after CCl4-induced toxic injury.
Mol Endocrinol. 2010 May;24(5):886-97. doi: 10.1210/me.2009-0286. Epub 2010 Mar 8.
3
Protective effects of calycosin against CCl4-induced liver injury with activation of FXR and STAT3 in mice.
Pharm Res. 2015 Feb;32(2):538-48. doi: 10.1007/s11095-014-1483-3. Epub 2014 Aug 21.
4
Mechanisms of STAT3 activation in the liver of FXR knockout mice.
Am J Physiol Gastrointest Liver Physiol. 2013 Dec;305(11):G829-37. doi: 10.1152/ajpgi.00155.2013. Epub 2013 Oct 3.
6
7
Obeticholic acid protects against carbon tetrachloride-induced acute liver injury and inflammation.
Toxicol Appl Pharmacol. 2017 Jan 1;314:39-47. doi: 10.1016/j.taap.2016.11.006. Epub 2016 Nov 16.
8
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation.
World J Gastroenterol. 2009 May 7;15(17):2097-108. doi: 10.3748/wjg.15.2097.
9
Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice.
Toxicol Appl Pharmacol. 2013 Oct 15;272(2):299-305. doi: 10.1016/j.taap.2013.06.016. Epub 2013 Jun 26.

引用本文的文献

1
Role of mitogens in normal and pathological liver regeneration.
Hepatol Commun. 2025 Apr 30;9(5). doi: 10.1097/HC9.0000000000000692. eCollection 2025 May 1.
2
Using different zebrafish models to explore liver regeneration.
Front Cell Dev Biol. 2024 Oct 31;12:1485773. doi: 10.3389/fcell.2024.1485773. eCollection 2024.
3
Characterisation of forkhead box protein A3 as a key transcription factor for hepatocyte regeneration.
JHEP Rep. 2023 Sep 12;5(12):100906. doi: 10.1016/j.jhepr.2023.100906. eCollection 2023 Dec.
5
Myeloid TLR4 signaling promotes post-injury withdrawal resolution of murine liver fibrosis.
iScience. 2023 Feb 16;26(3):106220. doi: 10.1016/j.isci.2023.106220. eCollection 2023 Mar 17.
7
Treatment with hepatocyte transplantation in a novel mouse model of persistent liver failure.
Biochem Biophys Rep. 2022 Nov 16;32:101382. doi: 10.1016/j.bbrep.2022.101382. eCollection 2022 Dec.
8
Sodium/taurocholate cotransporting polypeptide as target therapy for liver fibrosis.
Gut. 2022 Jul;71(7):1373-1385. doi: 10.1136/gutjnl-2020-323345. Epub 2021 Jul 15.
9
Farnesoid X receptor: a potential therapeutic target in multiple organs.
Histol Histopathol. 2020 Dec;35(12):1403-1414. doi: 10.14670/HH-18-301. Epub 2021 Jan 4.
10
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.
Nat Rev Gastroenterol Hepatol. 2021 Apr;18(4):223-238. doi: 10.1038/s41575-020-00381-6. Epub 2020 Dec 21.

本文引用的文献

3
4
Significance and mechanism of CYP7a1 gene regulation during the acute phase of liver regeneration.
Mol Endocrinol. 2009 Feb;23(2):137-45. doi: 10.1210/me.2008-0198. Epub 2008 Dec 4.
5
Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response.
Hepatology. 2008 Nov;48(5):1632-43. doi: 10.1002/hep.22519.
6
FXR: a metabolic regulator and cell protector.
Cell Res. 2008 Nov;18(11):1087-95. doi: 10.1038/cr.2008.289.
7
E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer.
Gastroenterology. 2008 Oct;135(4):1322-32. doi: 10.1053/j.gastro.2008.07.012. Epub 2008 Jul 17.
8
Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo.
Mol Endocrinol. 2008 Jul;22(7):1622-32. doi: 10.1210/me.2007-0527. Epub 2008 Apr 24.
10
FXR, a target for different diseases.
Histol Histopathol. 2008 May;23(5):621-7. doi: 10.14670/HH-23.621.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验